Favipiravir, an antiviral drug, in combination with tamoxifen exerts synergistic effect in tamoxifen-resistant breast cancer cells via hTERT inhibition
Crossref DOI link: https://doi.org/10.1038/s41598-024-51977-w
Published Online: 2024-01-22
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Fahim, Sally A. https://orcid.org/0000-0002-7934-5030
ElZohairy, Yehia A.
Moustafa, Rehab I.
Funding for this research was provided by:
New Giza University
Text and Data Mining valid from 2024-01-22
Version of Record valid from 2024-01-22
Article History
Received: 8 May 2022
Accepted: 10 January 2024
First Online: 22 January 2024
Competing interests
: The authors declare no competing interests.